KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gentex (GNTX) Cash & Equivalents (2016 - 2025)

Gentex (GNTX) has disclosed Cash & Equivalents for 16 consecutive years, with $179.6 million as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Cash & Equivalents changed N/A year-over-year to $179.6 million, compared with a TTM value of $179.6 million through Sep 2024, changed N/A, and an annual FY2023 reading of $226.4 million, up 5.44% over the prior year.
  • Cash & Equivalents was $179.6 million for Q3 2024 at Gentex, down from $260.2 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $423.4 million in Q4 2020 and bottomed at $179.6 million in Q3 2024.
  • Average Cash & Equivalents over 5 years is $270.8 million, with a median of $260.2 million recorded in 2024.
  • The sharpest move saw Cash & Equivalents surged 42.88% in 2020, then crashed 38.04% in 2021.
  • Year by year, Cash & Equivalents stood at $423.4 million in 2020, then crashed by 38.04% to $262.3 million in 2021, then dropped by 18.13% to $214.8 million in 2022, then increased by 5.44% to $226.4 million in 2023, then dropped by 20.67% to $179.6 million in 2024.
  • Business Quant data shows Cash & Equivalents for GNTX at $179.6 million in Q3 2024, $260.2 million in Q2 2024, and $226.4 million in Q4 2023.